Journal of Clinical Epidemiology
Volume 52, Issue 2 , Pages 129-136 , February 1999

Adjusted Odds Ratios Under Nondifferential Misclassification: Application to Prostate Cancer

  • Paul A. Godley

      Affiliations

    • Departments of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC USA
    • Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC USA
    • Corresponding Author InformationAddress correspondence to: Paul A. Godley, M.D., Ph.D., University of North Carolina at Chapel Hill, Division of Hematology/Oncology, 3009 Old Clinic Bldg., CB# 7305, Chapel Hill, NC 27599-7305
    • ,
  • Michael J. Schell

      Affiliations

    • Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC USA
    • Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC USA

,Accepted 13 October 1998.

References 

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6–29
  2. Whelan SL, Parkin DM, Masuyer E. Patterns of Cancer in Five Continents. Lyon, France: International Agency for Research on Cancer and Oxford University Press. IARC Scientific Publication No. 102; 1990;
  3. Carter HB, Coffey DS. The prostate (An increasing medical problem). Prostate. 1990;16:39–48
  4. Flanders WD. Review (Prostate cancer epidemiology). Prostate. 1984;5:621–629
  5. Checkoway H, DiFerdinando G, Hulka BS, Mickey DD. Medical, life-style, and occupational risk factors for prostate cancer. Prostate. 1987;10:79–88
  6. Rose DP. The biochemical epidemiology of prostatic carcinoma: In: Ip C, Birt DF, Rogers AE, Mettlin C, Eds. Dietary Fat and Cancer. Vol. 222. New York: Alan R. Liss, Inc., 1986: 43–68.
  7. Whittemore AS, Kolonel LN, Wu AH, et al.  Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada [see comments]. J Natl Cancer Inst. 1995;87:652–661
  8. Kleinbaum DG, Kupper LL, Morgenstern H. Information Bias. Epidemiologic Research: Principles and Quantitative Methods. New York: Van Nostrand Reinhold Company, 1982: 220–241.
  9. Begg CB. Methodological issues in studies of the treatment, diagnosis, and etiology of prostate cancer. Semin Oncol. 1994;21:569–579
  10. Dhom G. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol. 1983;106:210–218
  11. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes (Incidence, histology and morphometric observations). J Urol. 1989;141:1091–1094
  12. Winfield HN, Reddy PK, Lange PH. Coexisting adenocarcinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer. Urology. 1987;30:100–101
  13. Pritchett TR, Moreno J, Warner NE, Lieskovsky G, Nichols PW, Cook BA, et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol. 1988;139:1214–1216
  14. Mahadevia PS, Koss LG, Tar IJ. Prostatic involvement in bladder cancer, prostate mapping in 20 cystoprostatectomy specimens. Cancer. 1986;58:2096–2102
  15. Montie JE, Wood DP, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 1989;63:381–385
  16. Troncoso P, Babaian RJ, Ro JY, Grignon FJ, von Eschenbach AC, Ayala AG. Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology. 1989;34:52–56
  17. Davis BE, Weigel JW. Adenocarcinoma of the prostate discovered in 2 young patients following total prostatovesiculectomy for refractory prostatitis. J Urol. 1990;144:744–745
  18. Wellings SR. Development of human breast cancer. Adv Cancer Res. 1980;31:287–314
  19. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women (a study of 110 medicolegal autopsies). Br J Cancer. 1987;56:814–819
  20. Bisi H, Fernandes VS, de-Camargo RY, Koch L, Abdo AH, de-Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer. 1989;64:1888–1893
  21. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;71:4022–4029
  22. Ottino A, Pianzola HM, Castelletto RH. Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer. 1989;64:547–551
  23. Harach HR, Franssila KO, Wasenius V-M. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56:531–538
  24. Yatani R, Chigusa I, Akazaki K, Stemmerman GN, Welsh RA, Correa P. Geographic pathology of latent prostatic carcinoma. Int J Cancer. 1982;29:611–616
  25. Lee F, Littrup PJ, Torp PS, Mettlin C, McHugh TA, Gray JM, et al. Prostate cancer (Comparison of transrectal US and digital rectal examination for screening). Radiology. 1988;168:389–394
  26. Andersson SO, Baron J, Wolk A, Lindgren C, Bergstrom R, Adami HO. Early life risk factors for prostate cancer (A population-based case-control study in Sweden). Cancer Epidemiol Biomarkers Prev. 1995;4:187–192
  27. Agatstein EH, Hernandez FJ, Layfield LJ, Smith RB, deKernion JB. Use of the fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate (a clinical trial). J Urol. 1987;138:551–553
  28. U.S. Preventive Services Task Force. Screening for Prostate Cancer. Guide to Clinical Preventive Services, 2nd Edition. Washington, DC: U.S. Department of Health and Human Services, 1996: 119–139.
  29. Drago JR. Treatment advances in benign prostatic hyperplasia. Res Staff Phys. 1992;38:73–86
  30. Beier HR, Bruun J. Voiding pattern of men 60 to 70 years old (Population study in an urban population). J Urol. 1990;143:531–532
  31. Scott R, Mutchnik DL, Laskowski TZ, Schmalhorst WR. Carcinoma of the prostate in elderly men (Incidence, growth characteristics and clinical significance). J Urol. 1969;101:602–607
  32. Stemmermann GN, Nomura AM, Chyou PH, Yatani R. A prospective comparison of prostate cancer at autopsy and as a clinical event (The Hawaii Japanese experience). Cancer Epidemiol Biomarkers Prev. 1992;1:189–193
  33. Breslow N, Chan CW, Dhom G, Drury RAB, Franks LM, Gellei B, et al. Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer. 1977;20:680–688
  34. Lundberg S, Berg T. Prostatic carcinoma. An autopsy study. Scand J Urol Nephrol. 1970;4:93–97
  35. Liavag I. The localization of prostatic carcinoma. An autopsy study. Scand J Urol Nephrol. 1968;2:65–71
  36. Halpert B, Sheehan EE, Schmalhorst WR, Scott R. Carcinoma of the prostate. A survey of 5000 autopsies. Cancer. 1963;16:737–742
  37. Jordan WP, Kreager JA. Incidentally discovered microscopic carcinoma of the prostate. J Urol. 1967;97:751–754
  38. Suen KC, Lau LL, Yermakov V. Cancer and old age. Cancer. 1974;33:1164–1168

PII: S0895-4356(98)00152-8

Journal of Clinical Epidemiology
Volume 52, Issue 2 , Pages 129-136 , February 1999

Article Tools

* Image Usage & Resolution